Stock Track | MannKind Soars 6.03% After-Hours on Strong Q4 Earnings Beat

Stock Track

02/27

MannKind Corporation (MNKD) shares surged 6.03% in after-hours trading on Wednesday, following the release of the company's better-than-expected fourth-quarter financial results.

The biopharmaceutical company reported an operating income of $26.495 million for the quarter ended December 31, 2024, compared to an operating loss in the year-ago period. Net income came in at $7.422 million, or $0.03 per basic share, significantly outperforming analysts' estimates.

The strong quarterly performance likely fueled investor optimism, driving MannKind's stock higher in extended trading hours. However, more details on the company's revenue, pipeline updates, and forward guidance will be needed to assess the sustainability of the after-hours rally.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1188875274"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1188875274\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1188875274?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-27 05:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188875274","market":"us","top_or_hot":-1,"title":"Stock Track | MannKind Soars 6.03% After-Hours on Strong Q4 Earnings Beat","media":"Stock Track","content":"<p>MannKind Corporation (MNKD) shares surged 6.03% in after-hours trading on Wednesday, following the release of the company's better-than-expected fourth-quarter financial results.</p>\n\n<p>The biopharmaceutical company reported an operating income of $26.495 million for the quarter ended December 31, 2024, compared to an operating loss in the year-ago period. Net income came in at $7.422 million, or $0.03 per basic share, significantly outperforming analysts' estimates.</p>\n\n<p>The strong quarterly performance likely fueled investor optimism, driving MannKind's stock higher in extended trading hours. However, more details on the company's revenue, pipeline updates, and forward guidance will be needed to assess the sustainability of the after-hours rally.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | MannKind Soars 6.03% After-Hours on Strong Q4 Earnings Beat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | MannKind Soars 6.03% After-Hours on Strong Q4 Earnings Beat\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2025-02-27 05:46</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>MannKind Corporation (MNKD) shares surged 6.03% in after-hours trading on Wednesday, following the release of the company's better-than-expected fourth-quarter financial results.</p>\n\n<p>The biopharmaceutical company reported an operating income of $26.495 million for the quarter ended December 31, 2024, compared to an operating loss in the year-ago period. Net income came in at $7.422 million, or $0.03 per basic share, significantly outperforming analysts' estimates.</p>\n\n<p>The strong quarterly performance likely fueled investor optimism, driving MannKind's stock higher in extended trading hours. However, more details on the company's revenue, pipeline updates, and forward guidance will be needed to assess the sustainability of the after-hours rally.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MNKD","symbol_name":"曼恩凱德生物醫療","start_time":0,"source_url":"","article_id":"1188875274","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188875274","pubTimestamp":1740606394,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"MannKind Corporation  shares surged 6.03% in after-hours trading on Wednesday, following the release of the company's better-than-expected fourth-quarter financial results.The biopharmaceutical company reported an operating income of $26.495 million for the quarter ended December 31, 2024, compared to an operating loss in the year-ago period. Net income came in at $7.422 million, or $0.03 per basic share, significantly outperforming analysts' estimates.The strong quarterly performance likely fue","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MNKD":"曼恩凯德生物医疗"},"translate_title":"股票赛道MannKind因第四季度盈利强劲而盘后飙升6.03%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MNKD":1},"content_text":"MannKind Corporation (MNKD) shares surged 6.03% in after-hours trading on Wednesday, following the release of the company's better-than-expected fourth-quarter financial results.\nThe biopharmaceutical company reported an operating income of $26.495 million for the quarter ended December 31, 2024, compared to an operating loss in the year-ago period. Net income came in at $7.422 million, or $0.03 per basic share, significantly outperforming analysts' estimates.\nThe strong quarterly performance likely fueled investor optimism, driving MannKind's stock higher in extended trading hours. However, more details on the company's revenue, pipeline updates, and forward guidance will be needed to assess the sustainability of the after-hours rally.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}